Evaluation of the Effectiveness of a Regional Trauma Care System for the Treatment of Patients With Severe Trauma
Launched by PEKING UNIVERSITY PEOPLE'S HOSPITAL · Apr 4, 2023
Trial Information
Current as of November 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system for treating patients with severe trauma, which is serious physical injury that can lead to high rates of death and disability. The goal is to see if this regional trauma care system, designed to fit the needs of China, can improve the way patients receive care after a serious injury. The study will involve multiple hospitals and will look at how effectively this system works for patients who have experienced significant trauma.
To participate in this trial, patients need to be between 18 and 60 years old and must have a severe injury, defined as having a specific score that indicates their condition is critical. They also need to arrive at the hospital within 24 hours of their injury. However, individuals with certain health issues, like serious diseases or organ problems, will not be eligible to join. Participants can expect to receive care under this new system, and their outcomes will be monitored to see how well it works compared to traditional methods. This is an important step in improving trauma care and potentially saving lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age of 18-60 years old, with no restriction on gender;
- • 2. Severe trauma, including trauma patients with ISS score ≥ 16;
- • 3. Time from trauma to admission \<24h.
- Exclusion Criteria:
- • 1. Patients who complicated with underlying diseases, such as malignant tumor and diabetes mellitus;
- • 2. Patients with important organ dysfunction before trauma;
- • 3. The investigator considers not appropriate for enrollment. -
About Peking University People's Hospital
Peking University People's Hospital is a leading clinical research institution in China, renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. Affiliated with Peking University, the hospital integrates cutting-edge research, comprehensive healthcare services, and a multidisciplinary team of experts to facilitate the development of new therapies and medical interventions. With a strong focus on patient safety and ethical standards, Peking University People's Hospital is dedicated to conducting rigorous clinical trials that contribute to the global medical community and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials